A drug harms ranking study for Aotearoa New Zealand
Dr Rose Crossin Department of Population Health – University of Otago, Christchurch Drug harm is a significant public health burden in Aotearoa New Zealand (1,2,3); though harms are not evenly…
Cannabis-based medicinal products for the treatment of Long COVID symptoms: current and potential applications
Authors Hannah Thurgur, Anne Katrin Schlag, Elizabeth Iveson, Adele Hosseini, Michael Lynskey, David J. Nutt Published August 31, 2023 Abstract Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection can result in…
Medicinal cannabis for treating PTSD and comorbid depression: Real World Evidence from Project T21
Authors Michael Lynskey, Alkyoni Athanasiou-Fragkouli, Hannah Thurgur, Anne Schlag and David Nutt Published March 12, 2024 Background Cannabis-based medicinal products (CBMPs) are increasingly being used to treat post-traumatic stress disorder…
Prescribed Medicinal Cannabis for the Treatment of Chronic Pain Comorbid with Depression: Real World Evidence from Project Twenty21
Authors Alkyoni Athanasiou-Fragkouli, Michael Lynskey, Anne Schlag and David Nutt Published June 5, 2024 Background Chronic pain is one of the most common conditions for which people seek treatment with…
Prescribed Medical Cannabis Use Among Older Individuals: Patient Characteristics and Improvements in Well‑Being: Findings from T21
Authors Michael T Lynskey, Hannah Thurgur, Alkyoni Athanasiou‑Fragkouli, Anne K. Schlag and David J. Nutt Published June 17, 2024 Abstract Background Previous research has suggested that the use of cannabis-based…
Suicidal Ideation in Medicinal Cannabis Patients: A 12-Month Prospective Study
Authors Michael T Lynskey, Hannah Thurgur, Alkyoni Athanasiou‑Fragkouli, Anne K. Schlag and David J. Nutt Published July 24, 2024 Abstract Objective To document the prevalence and correlates of suicidal ideation…
Medical cannabis could save NHS £4 billion each year
Allowing medical cannabis to be prescribed on the NHS for chronic pain could save the state healthcare provider almost £4 billion annually, according to a new research study. The research…
The Australia story: Current status and future challenges for the clinical applications of psychedelics
Authors David J Nutt, Peter Hunt, Anne Katrin Schlag and Paul Fitzgerald Published December 19, 2024 Abstract The past decade has seen a huge increase in clinical research with psychedelic…
Drug development in psychiatry: 50 years of failure and how to resuscitate it
Authors David J Nutt Published February 11, 2025 Abstract The past 50 years have seen remarkable advances in the science of medicine. The pharmacological treatments of disorders such as hypertension,…
